Latest Health News
WHO Launches Guideline on Environmentally Friendly Oral Health Care
To mark World Oral Health Day 2026, WHO is hosting a webinar on March 19 to launch its new guideline promoting less invasive, environmentally sustainable methods for preventing and managing dental caries. The event features WHO Director-General Dr. Tedros and experts discussing recommendations that support primary health care and the Minamata Convention on Mercury. Registration is available via Zoom with multilingual interpretation.
New CAR-T Cell Method Prolongs Effectiveness Against Cancer and HIV
Albert Einstein College of Medicine researchers developed a multi-cytokine scaffold (HCW9206) using IL-7, IL-15, and IL-21 to produce longer-lasting CAR-T cells. In mouse models, these cells showed superior control of blood cancers and HIV suppression compared to standard methods. The approach aims to reduce relapses and enable functional cures.
Debate on Overblown Panic Over Global Health Funding Cuts
Despite US cuts and WHO exit, remaining WHO funding exceeds $4 billion for 2026-27, with 75% secured; aid reductions are minor for most regions reliant on domestic spending. Experts argue efficiency gains and national priorities can offset shortfalls amid shifting geopolitics.
LCRF and AstraZeneca Award Grants for Small Cell Lung Cancer Research
The Lung Cancer Research Foundation announced two $500,000 grants with AstraZeneca targeting SCLC treatment strategies and patient advocacy to improve outcomes. Focus areas include biomarkers like DLL3 and translational research to boost survivorship across the care continuum.
Africa CDC Calls for Reformed Global Health Ecosystem
Leaders from Africa, Europe, and beyond met in Addis Ababa to address declining financing, climate impacts, and disease burdens, emphasizing country-led systems with multilateral support. The declaration prioritizes universal health coverage, primary care, and empowered regional institutions like Africa CDC.
Penn Medicine Advances Treatments for Cavernous Malformations
Penn Medicine led enrollment in a REC-994 trial, an oral superoxide scavenger showing promise for symptomatic cavernous malformations, now with orphan drug status. Researchers are planning rapamycin trials targeting mTOR signaling to regress lesion growth non-invasively.
Experts Advocate Risk-Based Regulation for Nicotine Products
Global health leaders urge risk-proportionate nicotine regulations to integrate harm reduction, potentially saving 14 million lives in 23 nations by 2060 and over 100 million globally. Current policies could be doubled in effectiveness with these strategies.
NIH-Funded AI Tool Enhances Routine Medical Scans
The Merlin AI model predicts diagnoses from scans with 81% accuracy and forecasts risks like diabetes or heart disease 75% of the time up to five years ahead. It outperforms specialized systems across hundreds of conditions.
Europe Debates Medical Sovereignty Amid Supply Chain Strains
Geopolitical tensions, US WHO withdrawal, and shortages challenge EU health systems; new pharmaceutical rules and Critical Medicines Act aim to boost production and reduce dependencies. Discussions at Euronews Health Summit will assess readiness.
Johnson & Johnson Reports Strong Erda-iDRS Results in Bladder Cancer
First-in-human data from EAU 2026 shows 89% complete response rate in intermediate-risk non-muscle-invasive bladder cancer, with durable responses over 18 months. The treatment highlights promising advancements in targeted therapies.
CRISPR Activation Boosts Mitochondria in Heart Cells
Weekly CRISPR news highlights transcriptional activation of PPARGC1A via CRISPRa, increasing mitochondria in human cardiomyocytes by upregulating key programs. This could advance cardiac therapies.
Air Pollution Worsens Health Post-Cancer Diagnosis
A March 2026 GeoHealth webinar discusses air pollution's impacts on cancer survivors, emphasizing strategies to improve post-diagnosis life. Findings underscore environmental factors in ongoing health management.